Michael Dake from the Stanford University School of Medicine in Stanford, California, attended the CIRSE, or Cardiovascular and Interventional Radiological Society of Europe conference in Munich that was held on Sunday, September 11, 2011. He gave a compelling talk entitled ‘Hot Topics Session: CCSVI is real, and IRs should treat it with venoplasty’.
Dake’s talk is still being shared across the internet by people interested in CCSVI and its relationship to MS in places such as the ‘This is MS’ forum. So we thought we would do a quich recap on the main points Dake made.
In the talk’s accompanying article Dake wrote that regardless of where you stand on the concept of chronic cerebrospinal venous insufficiency (CCSVI) and its suggested association with multiple sclerosis (MS), it is very clear that medical phenomenon creates many questions for interventionalists, for which the answers are not yet readily available. Whether a weary sceptic, open-minded onlooker, confused clinician, volatile critic or converted believer, no one is indifferent and all must agree that nothing in recent history has shaken this particular field with such an emotionally divisive force as CCSVI.
He identified three key questions on the subject:
1. Does the treatment of CCSVI cure MS?
2. Does CCSVI have a vital role in causing MS?
3. Does endovascular therapy create patient benefits beyond a placebo effect?
To read what he had said to say on those questions check out a user friendly version of the article on the CCSVI Alliance Facebook page.
To talk to our case manager about CCSVI treatment at Angeles Health in Mexico, where we have an interventional cardiologist who also trained at Stanford University as well as neurologist working on every CCSVI procedure and ensure every CCSVI patient stays in hospital for up to 5 days after their treatment, please just contact us using the form on the right.